Literature DB >> 8872965

Serum total renin is increased before microalbuminuria in diabetes.

T J Allen1, M E Cooper, R E Gilbert, J Winikoff, S L Skinni, G Jerums.   

Abstract

Serum prorenin is increased in patients with insulin dependent diabetes mellitus (IDDM) with microvascular complications. The present longitudinal study investigated whether increases in serum total renin concentration (TRC, active+prorenin) can predict the development of microalbuminuria in IDDM patients over a 10 year period. TRC and albumin excretion rates (AER) were determined in 78 IDDM patients who were followed longitudinally for 10.4 +/- 0.2 (mean +/- SE) years. Twelve patients had progressively increasing albuminuria (progressors), and these were compared to 66 patients in whom albuminuria did not rise (non-progressors). The two groups had similar duration of diabetes, age, follow-up, glycemic control and blood pressure at the start of the study. Serum TRC was increased in progressors [350 (1.1) mIU/liter, geometric mean (tolerance factor)] compared to non-progressors [189 (1.2)] after 5 to 10 years duration of diabetes, and continued to rise in this group, reaching a mean of 923 mIU/liter (normal range 131 to 170) after 20 years of diabetes. When serial measurements of TRC and AER were compared in individual progressors, a significant increase in TRC was apparent up to five years before the onset of microalbuminuria. Microalbuminuria in patients with IDDM is preceded by a substantial increase in serum TRC, suggesting that serum TRC may predict the subsequent development of incipient nephropathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872965     DOI: 10.1038/ki.1996.390

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Is it possible to predict diabetic kidney disease?

Authors:  S M Thomas; G C Viberti
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

2.  Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay.

Authors:  H Yokota; F Mori; K Kai; T Nagaoka; N Izumi; A Takahashi; T Hikichi; A Yoshida; F Suzuki; Y Ishida
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  High plasma prorenin in non diabetic siblings of non insulin-dependent diabetes mellitus patients.

Authors:  N Glorioso; C Troffa; G Tonolo; F Filigheddu; F Dettori; M Ciccarese; A Saller; A Soro; E Brocco; P Pinna-Parpaglia; F Mantero; P P Faronato; R Nosadini; M Maioli
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

Review 4.  Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

Authors:  K L Goa; M Haria; M I Wilde
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

5.  (Pro)renin receptor: a treatment target for diabetic retinopathy?

Authors:  Jennifer L Wilkinson-Berka; Duncan J Campbell
Journal:  Diabetes       Date:  2009-07       Impact factor: 9.461

6.  AMPK couples plasma renin to cellular metabolism by phosphorylation of ACC1.

Authors:  Scott A Fraser; Suet-Wan Choy; Núria M Pastor-Soler; Hui Li; Matthew R P Davies; Natasha Cook; Marina Katerelos; Peter F Mount; Kurt Gleich; Jennifer L McRae; Karen M Dwyer; Bryce J W van Denderen; Kenneth R Hallows; Bruce E Kemp; David A Power
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.